STATESVILLE, N.C. - Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its third quarter ended January 31, 2014.

Net earnings for the quarter were $604,000, or $0.22 per diluted share, as compared to net earnings of $544,000, or $0.21 per diluted share, in the third quarter last year. Earnings for the quarter benefited from lower operating costs.

Sales for the quarter were $26,013,000, a decline of 5% from sales of $27,450,000 in the third quarter last year. Domestic sales were $21,544,000, up 5% from sales of $20,445,000 in the third quarter last year. Sales for the quarter benefited from the shipment of several large domestic orders received by the Company in earlier periods.

The domestic laboratory construction marketplace continued to be challenging during the quarter, as fewer project opportunities were available of all sizes, public and private. International sales were $4,469,000, a decline of 36% from unusually strong sales of $7,005,000 in the third quarter last year. However, incoming international orders were well above the third quarter last year, as the Company successfully took advantage of a growing number of project opportunities in Asia and the Middle East.

The order backlog was $69.8 million at January 31, 2014, up slightly from $69.5 million at October 31, 2013, and down from $84.5 million at January 31, 2013. International orders in the backlog increased during the quarter, offsetting a decline in domestic orders. The order backlog is expected to increase in the fourth quarter of the current fiscal year, as the Company was recently notified of a large international contract award.

Net earnings for the nine months ended January 31, 2014 were $2,916,000, or $1.11 per diluted share, as compared to net earnings of $1,827,000, or $0.71 per diluted share, in the comparable period last year. Earnings in the current year benefited from a favorable product mix and lower operating costs.

Sales for the nine months ended January 31, 2014 were $84,114,000, a decline of 1% from sales of $85,318,000 in the comparable period last year. Domestic sales for the nine months ended January 31, 2014 were $70,678,000, an increase of 3% from sales of $68,757,000 in the comparable period last year. International sales were $13,436,000, a decline of 19% from sales of $16,561,000 in the comparable period last year.

Cash on hand was $7.3 million at the end of the quarter, as compared to $4.9 million at the end of the same period last year. Short-term borrowings under the Company's bank line of credit were $3.9 million, as compared to $2.4 million at the end of the same period last year, and long-term debt was $4.7 million, as compared to $3.5 million. The debt-to-equity ratio was .28-to-1, as compared to .20-to-1 at the end of the same period last year. Working capital was $25.5 million, as compared to $24.3 million at the end of the same period last year.

"We continued to make excellent progress during the quarter," said David M. Rausch, Kewaunee's Chief Executive Officer. "I am pleased with sales and earnings, particularly since the third quarter is historically our slowest due to normal construction cycles and the large number of holidays. Also, we continued to make good progress in the quarter against our goals to strengthen the Kewaunee brand, strengthen relationships with existing customers, build relationships with new and prospective customers, reduce costs, and increase market share.

"Our Associates in Statesville did an excellent job controlling manufacturing and operating costs during the quarter. These lower costs are allowing us to continue to be very competitive in the domestic marketplace where fewer new projects available have intensified pressure on project selling prices. Our international team also made excellent progress during the quarter in winning projects, expanding and strengthening the Kewaunee sales organization, and strengthening the Kewaunee brand name globally.

"Looking forward, we expect that the financial results for the fourth quarter will likely be in line with, or slightly better than, the past two quarters."

Kewaunee Scientific Corporation is a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products. Laboratory furniture products include both steel and wood cabinetry, fume hoods, adaptable modular systems, moveable workstations, biological safety cabinets, and epoxy resin counters and sinks. Healthcare furniture products include laminate casework, storage systems, and related products for healthcare applications. Technical furniture products include column systems, slotted-post systems, pedestal systems, and stand-alone benches.

The Company's corporate headquarters are located in Statesville, North Carolina. Three manufacturing facilities are located in Statesville, NC serving the domestic and international markets. One manufacturing facility is located in Bangalore, India serving the local and Asian markets. The Company has subsidiaries in Singapore and India. Kewaunee Scientific's website is located at http://www.kewaunee.com.